share: The 2018 fourth quarter included a roughly 89 million gain on forward contracts for the issuance of convertible preferred stock, in connection with a 300 million investment by China's Harbin Pharmaceutical Group Co., Ltd., or Hayao, aimed at creating joint ventures in Hong Kong and mainland China, according to Market Watch. That investment was completed in November. Pittsburgh-based GNC GNC, 1.23% said it had net income of 58.8 million, or 62 cents a share, in the fourth quarter, after a loss of 212.7 million, or 3.03 a share, in the year-earlier period, when it booked impairment charges. The numbers also include a 24 million non-cash long-lived asset impairment charge related to an indefinite-lived intangible asset. The Fact Set consensus was for of EPS of 3 cents. Excluding those items, the company said it had an adjusted loss of 13 cents a share.
(news.financializer.com). As
reported in the news.
Tagged under share, investment topics.